Primary Antibodies
Secondary Antibodies
Proteins & Peptides
ELISA Kits
About Us
Contact Us
Antibodies.com Logo Antibodies.com Logo
Sign In/Register
0
ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

LILRB3 Positive Control (A56560)

Antibodies.com Image Placeholder - Discover more for less
Antibodies.com Image Placeholder - Discover more for less
$340
100% Guarantee
Price Match Guarantee
Request a Quotation
Custom or Bulk Request

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 6-9 business days.

  • Specifications

Name
LILRB3 Positive Control
Applications
WB
Recommended Dilutions
Western Blot: 1:500
Storage
-20°C for long term storage
Synonyms
CD85 antigen-like family member A, CD85a, ILT-5, ILT5, Immunoglobulin-like transcript 5, Leukocyte immunoglobulin-like receptor 3, Leukocyte immunoglobulin-like receptor subfamily B member 3, LIR-3, LIR3, Monocyte inhibitory receptor HL9
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using LILRB3 Positive Control (A56560)? Please let us know so that we can list the citation on this page.

Alternative products to LILRB3 Positive Control (A56560)

Antibodies.com Image Placeholder - Discover more for less
A55548
LILRB3 Blocking Peptide
Validated for Immunodepletion, Immunocompetition.
Antibodies.com Image Placeholder - Discover more for less
A55547
LILRB3 Blocking Peptide
Validated for Immunodepletion, Immunocompetition.
Antibodies.com Image Placeholder - Discover more for less
A55548
LILRB3 Blocking Peptide
Validated for Immunodepletion, Immunocompetition.
Antibodies.com Image Placeholder - Discover more for less
A55547
LILRB3 Blocking Peptide
Validated for Immunodepletion, Immunocompetition.

Proteins predicted to interact with LILRB3

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
92.7% Relevancy Score
83.8% Relevancy Score
79.1% Relevancy Score
69.3% Relevancy Score
68.8% Relevancy Score
68.5% Relevancy Score
65.8% Relevancy Score
63.8% Relevancy Score
57.5% Relevancy Score